---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T12:15:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
webUrl: "https://technews.tmcnet.com/news/2023/01/11/9741357.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "2oLy3DSFvCiwrxZuVxvXiMvVCBVGltqSmKzQrxbv/6UNSC9TMeaQu3fY1sFWUWw8mg1CBr3HZFzk1e39K5Ee3SUSPEc+a0LOqWmma1EPs7X0bqvsBXkQzcO6ThT551uHu5k5ebCtU6DnM5a73xpvd2lBa+pvib48gKs+j0UowsAMwgtiZ5VREY73W6wlojSY16Bb7PgLTitVWGSxjAGJdVP0ZnOQ1KXQS/scSl2bnDhlf9GOHQoY3xdS9zsKRj2A0FptPKt0sQ0FdkWAdAqoDL5CR7tCpIpxJ+35wHtMz+JlIM9ynLgjqKcjw1KGrqxIIEJZJ/HS84hiIj35ktXXndqUV6q3vvLJ7ystKPId8x8=;K1adRqR5T+9USLPqZzDw0g=="
---

